241 related articles for article (PubMed ID: 23375937)
1. Glial cell modulators attenuate methamphetamine self-administration in the rat.
Snider SE; Hendrick ES; Beardsley PM
Eur J Pharmacol; 2013 Feb; 701(1-3):124-30. PubMed ID: 23375937
[TBL] [Abstract][Full Text] [Related]
2. The glial cell modulators, ibudilast and its amino analog, AV1013, attenuate methamphetamine locomotor activity and its sensitization in mice.
Snider SE; Vunck SA; van den Oord EJ; Adkins DE; McClay JL; Beardsley PM
Eur J Pharmacol; 2012 Mar; 679(1-3):75-80. PubMed ID: 22306241
[TBL] [Abstract][Full Text] [Related]
3. The glial cell modulator and phosphodiesterase inhibitor, AV411 (ibudilast), attenuates prime- and stress-induced methamphetamine relapse.
Beardsley PM; Shelton KL; Hendrick E; Johnson KW
Eur J Pharmacol; 2010 Jul; 637(1-3):102-8. PubMed ID: 20399770
[TBL] [Abstract][Full Text] [Related]
4. Ibudilast reverses the decrease in the synaptic signaling protein phosphatidylethanolamine-binding protein 1 (PEBP1) produced by chronic methamphetamine intake in rats.
Charntikov S; Pittenger ST; Thapa I; Bastola DR; Bevins RA; Pendyala G
Drug Alcohol Depend; 2015 Jul; 152():15-23. PubMed ID: 25962787
[TBL] [Abstract][Full Text] [Related]
5. Ibudilast attenuates expression of behavioral sensitization to cocaine in male and female rats.
Poland RS; Hahn Y; Knapp PE; Beardsley PM; Bowers MS
Neuropharmacology; 2016 Oct; 109():281-292. PubMed ID: 27343385
[TBL] [Abstract][Full Text] [Related]
6. Minocycline, an antibiotic with inhibitory effect on microglial activation, attenuates the maintenance and reinstatement of methamphetamine-seeking behavior in rat.
Attarzadeh-Yazdi G; Arezoomandan R; Haghparast A
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Aug; 53():142-8. PubMed ID: 24768984
[TBL] [Abstract][Full Text] [Related]
7. Developmental lead exposure alters methamphetamine self-administration in the male rat: acquisition and reinstatement.
Rocha A; Valles R; Bratton GR; Nation JR
Drug Alcohol Depend; 2008 May; 95(1-2):23-9. PubMed ID: 18242880
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of buspirone for attenuating cocaine and methamphetamine reinstatement in rats.
Shelton KL; Hendrick ES; Beardsley PM
Drug Alcohol Depend; 2013 May; 129(3):210-6. PubMed ID: 23374566
[TBL] [Abstract][Full Text] [Related]
9. Ibudilast attenuates subjective effects of methamphetamine in a placebo-controlled inpatient study.
Worley MJ; Swanson A-N; Heinzerling KG; Roche DJ; Shoptaw S
Drug Alcohol Depend; 2016 May; 162():245-50. PubMed ID: 26993372
[TBL] [Abstract][Full Text] [Related]
10. Ibudilast (AV411), and its AV1013 analog, reduce HIV-1 replication and neuronal death induced by HIV-1 and morphine.
El-Hage N; Rodriguez M; Podhaizer EM; Zou S; Dever SM; Snider SE; Knapp PE; Beardsley PM; Hauser KF
AIDS; 2014 Jun; 28(10):1409-19. PubMed ID: 24732776
[TBL] [Abstract][Full Text] [Related]
11. The glial cell modulator ibudilast attenuates neuroinflammation and enhances retinal ganglion cell viability in glaucoma through protein kinase A signaling.
Cueva Vargas JL; Belforte N; Di Polo A
Neurobiol Dis; 2016 Sep; 93():156-71. PubMed ID: 27163643
[TBL] [Abstract][Full Text] [Related]
12. Reduction of opioid withdrawal and potentiation of acute opioid analgesia by systemic AV411 (ibudilast).
Hutchinson MR; Lewis SS; Coats BD; Skyba DA; Crysdale NY; Berkelhammer DL; Brzeski A; Northcutt A; Vietz CM; Judd CM; Maier SF; Watkins LR; Johnson KW
Brain Behav Immun; 2009 Feb; 23(2):240-50. PubMed ID: 18938237
[TBL] [Abstract][Full Text] [Related]
13. Ibudilast suppresses TNFalpha production by glial cells functioning mainly as type III phosphodiesterase inhibitor in the CNS.
Suzumura A; Ito A; Yoshikawa M; Sawada M
Brain Res; 1999 Aug; 837(1-2):203-12. PubMed ID: 10434004
[TBL] [Abstract][Full Text] [Related]
14. Ibudilast produces anti-allodynic effects at the persistent phase of peripheral or central neuropathic pain in rats: Different inhibitory mechanism on spinal microglia from minocycline and propentofylline.
Fujita M; Tamano R; Yoneda S; Omachi S; Yogo E; Rokushima M; Shinohara S; Sakaguchi G; Hasegawa M; Asaki T
Eur J Pharmacol; 2018 Aug; 833():263-274. PubMed ID: 29886243
[TBL] [Abstract][Full Text] [Related]
15. Differences in extinction responding and reinstatement of methamphetamine-seeking behavior between Fischer 344 and Lewis rats.
Kruzich PJ; Xi J
Pharmacol Biochem Behav; 2006 Mar; 83(3):391-5. PubMed ID: 16574207
[TBL] [Abstract][Full Text] [Related]
16. Administration of the glial cell modulator, minocycline, in the nucleus accumbens attenuated the maintenance and reinstatement of morphine-seeking behavior.
Arezoomandan R; Haghparast A
Can J Physiol Pharmacol; 2016 Mar; 94(3):257-64. PubMed ID: 26745749
[TBL] [Abstract][Full Text] [Related]
17. Extended methamphetamine self-administration in rats results in a selective reduction of dopamine transporter levels in the prefrontal cortex and dorsal striatum not accompanied by marked monoaminergic depletion.
Schwendt M; Rocha A; See RE; Pacchioni AM; McGinty JF; Kalivas PW
J Pharmacol Exp Ther; 2009 Nov; 331(2):555-62. PubMed ID: 19648469
[TBL] [Abstract][Full Text] [Related]
18. Oxytocin decreases methamphetamine self-administration, methamphetamine hyperactivity, and relapse to methamphetamine-seeking behaviour in rats.
Carson DS; Cornish JL; Guastella AJ; Hunt GE; McGregor IS
Neuropharmacology; 2010 Jan; 58(1):38-43. PubMed ID: 19560473
[TBL] [Abstract][Full Text] [Related]
19. Minocycline blocks glial cell activation and ventilatory acclimatization to hypoxia.
Stokes JA; Arbogast TE; Moya EA; Fu Z; Powell FL
J Neurophysiol; 2017 Apr; 117(4):1625-1635. PubMed ID: 28100653
[TBL] [Abstract][Full Text] [Related]
20. Allosteric inhibition of macrophage migration inhibitory factor revealed by ibudilast.
Cho Y; Crichlow GV; Vermeire JJ; Leng L; Du X; Hodsdon ME; Bucala R; Cappello M; Gross M; Gaeta F; Johnson K; Lolis EJ
Proc Natl Acad Sci U S A; 2010 Jun; 107(25):11313-8. PubMed ID: 20534506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
